Companies

Cook Medical has launched the Biodesign® ENT Repair Graft, which acts as an adjunct to aid in the natural healing process following nasal and sinus mucosal surgery. The product is designed for rhinologists who treat patients that suffer from difficult-to-heal conditions in the nasal passages.

Boston Scientific Corporation has launched a clinical trial to determine whether occipital nerve stimulation using the company’s Precision™ System can safely and effectively treat chronic migraine when used in conjunction with anti-migraine medications.

St. Jude Medical, Inc. has reported sales and net earnings for the second quarter ended June 29, 2013. Background We … continue reading “Mixed Bag for St.Jude Medical Sees Cardiac Rhythm Business Propped Up by The Rest”

Australia’s regulatory authority, the Therapeutic Goods Administration (TGA) has issued a hazard alert pertaining to one of Medtronic’s pacing devices, the Consulta Cardiac Resynchronization Therapy Pacemaker (CRT-P). The action coincides with the company’s recall of certain Consulta and Syncra CRT-P devices.

Italy’s Sorin Group has issued a press release in which it confirms it will be participating in the manufacture of … continue reading “Sorin and Boston Scientific in TAVI Manufacturing Tie-up”

In its quarterly financial statement Johnson & Johnson says its sales of $17.9 billion for the second quarter of 2013, represent an increase of 8.5% as compared to the second quarter of 2012. This figure includes the impact of the acquisition of Synthes, Inc., net of the divestiture of the DePuy trauma business.

Abbott’s purse strings are undeniably loose as it announces another acquisition, this time of ophthalmic device company OptiMedica Corporation. The acquisition will enable Abbott to expand its vision care business into the femtosecond laser-assisted cataract surgery market.

Abbott has entered into an agreement to purchase IDEV Technologies, a privately held company focused on developing next-generation medical devices … continue reading “Abbott’s New Acquisition Signals Intent in Global Peripheral Artery Disease Market”

Boston Scientific Corporation has received U.S. FDA 510(k) clearance and CE Mark approval for the Guidezilla™ Guide Extension Catheter and … continue reading “FDA/CE Nod And Launch For Boston Sci’s Guidezilla™ Guide Extension Catheter”

Medtronic has issued a press release relating to a the ruling by a court in Mannheim Germany that its CoreValve® Transcatheter Valve System infringes a patent owned by Edwards Lifesciences. Suffice it to say they’re not happy.

Medtronic, Inc. has announced the global market introduction of the CD HORIZON® SOLERA® Spinal System Sagittal Adjusting Screw (SAS) which … continue reading “Medtronic’s New Screw for Medtronic’s CD HORIZON® SOLERA® Spinal System Offers Enhanced Positioning”

It’s sports med week this week, with the annual gathering that is the AOSSM meeting taking place in Chicago. Mitek Sports Medicine, a DePuy Synthes Company, under the wing of Johnson & Johnson, has used the event to showcase its new HEALIX ADVANCE™ KNOTLESS Anchor, a new suture anchor it says is designed to provide optimal knotless fixation for rotator cuff repair.

Zimmer Spine, Inc. has begun distributing its APEX Spine System, a comprehensive set of implants and instruments designed to safely and effectively correct a broad range of spinal deformities, as well as complex and degenerative spinal diseases. Under the terms of a long-term agreement with SpineCraft (Westmont, IL), Zimmer Spine will exclusively market the APEX Spine System to healthcare organizations across the United States, Canada, Australia and New Zealand.

Abbott has announced that Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved the XIENCE Xpedition™ Everolimus Eluting Coronary … continue reading “Japanese Approval For Abbott’s XIENCE Xpedition™ Drug Eluting Stent”

Last month we covered the EU launch of Boston Scientific’s respiration-sensitive Vitalio™ pacemaker. Now the company has announced the first post-launch implantation of the device, which has taken place at a Dutch hospital.

Preliminary second quarter figures from surgical robotics company Intuitive Surgical, Inc. are some way off the company’s predictions. Q2 projections included sales of over $620M, which would have been a 16%+ ramp, but actual sales came in at $575M, only a 7% increase over prior year.